Home › Trial NCT05007652
A Study of KRN125 in Patients With Multiple Myeloma and Malignant Lymphoma
- Trial IDNCT05007652
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorKyowa Kirin Co., Ltd.
- Enrollment64
- Start date2021-09-01
- ConditionsMultiple Myeloma and Malignant Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.